GLP-1 analog-COL3A1 fusion protein (Shanghai Humantech Biotechnology)

GLP‑1类似物‑COL3A1融合蛋白（ 上海惠盾生物）

Report date: 2026/03/12 20:00:16

Base Information

Drug NameGLP-1 analog-COL3A1 fusion protein (Shanghai Humantech Biotechnology)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptideBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsHyperglycemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Humantech Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Humantech Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsHyperglycemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A